pindolol has been researched along with quinpirole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Cheng, JT; Hsu, CT; Lai, CW; Lee, TL; Yen, ST | 1 |
2 other study(ies) available for pindolol and quinpirole
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Activation of beta3-adrenoceptors by exogenous dopamine to lower glucose uptake into rat adipocytes.
Topics: Adipocytes; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Benzazepines; Biological Transport; Cyclic AMP; Deoxyglucose; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Fenoldopam; Glucose; Immunoglobulins, Intravenous; Male; Pindolol; Prazosin; Propranolol; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Thionucleotides | 1998 |